HER2 Positive OR TROP2 Positive Non-Small Cell Lung Cancer
1 clinical trials · Condition
◉ Watch HER2 Positive OR TROP2 Positive Non-Small Cell Lung Cancer
| Record | Firm | Date |
|---|---|---|
| Study on the Mechanism of ADC Drug Evaluation Based on Immune Co-culture of Lung Cancer Organoids (NCT07610616) | Guangzhou Institute of Respiratory Disease | 2025-12-28 |
Track HER2 Positive OR TROP2 Positive Non-Small Cell Lung Cancer automatically
Every clearance here is in the API, with alerts when new ones post.